Skip to main content
Hit enter to search or ESC to close
Close Search
Chemotargets
Menu
  • About
  • Products
    • SafetySuite
    • SafetyVista
    • CIPsee
    • CLARITY
  • Services
    • Drug Safety
    • Repurposing
    • Discovery
  • Pipeline
  • Science
  • News
  • Careers
  • Contact
    By Carina Oliver In Press Release

    IQCC-UdG and Chemotargets join forces to give a second life to forgotten molecules in the laboratory

    The aim of the agreement is to analyse the molecules synthesised by IQCC researchers over the past three decades to…
    Read More

    Acellera and Chemotargets to collaborate enhancing AI and Physics-based Drug Discovery

    By Montserrat CasesNews, Science

    A formal collaboration to advance a common internal pipeline of drug development projects   Barcelona, 16 March 2022 – Today we announce the start of the formal collaboration between Acellera…

    Read More
    2022-03-16
    Love0
    News collection CloudScientific logo

    CloudScientific and Chemotargets announce a new partnership to advance translational safety analysis in China

    By Montserrat CasesNews, Science

    CloudScientific as the local distributor in China of Chemotargets’ CLARITY and CLARITY PV technology platforms Shanghai, China and Barcelona, Spain – January 17th, 2022. Chemotargets is proud to appoint CloudScientific as the local…

    Read More
    2022-01-17
    Love0
    News collection

    Chemotargets and the CRG ally to accelerate the development of new treatments

    By Montserrat CasesNews, Science
    Drug discovery biotech firm Chemotargets and the Centre for Genomic Regulation (CRG) have signed a strategic agreement to accelerate the development of new targeted therapies that respond to unmet clinical...
    Read More
    2021-10-26
    Love0

    Chemotargets launches CLARITY PV, a new web-based platform for translational safety and pharmacovigilance

    By Montserrat CasesNews, Products

    This week Chemotargets announces the launch of CLARITY PV, a new product for translational safety and pharmacovigilance professionals. Barcelona, July 5th, 2021. Chemotargets launches CLARITY PV, a new web-based platform…

    Read More
    2021-07-05
    Love0
    News collection

    Chemotargets has been awarded the Innovative SME Seal from the Spanish Ministry of Science and Innovation

    By Montserrat CasesNews

    The Innovative SME Seal, valid for three years, recognizes the high level of innovation in the projects, products and services of Chemotargets. Barcelona, June 1st, 2021. Chemotargets has been awarded…

    Read More
    2021-06-03
    Love0
    News collection

    Chemotargets Announces First AI-Designed Drug for Huntington’s Disease to Enter Clinical Trials

    By Montserrat CasesNews, Science

    In less than 12 months, the collaboration between Chemotargets and Galyan Bio yields a scaffold for first-in-class clinical candidates in difficult area of neurodegenerative disease. Chemotargets employed its proprietary AI-driven…

    Read More
    2021-04-22
    Love0
    News collection

    Chemotargets, a new phase of growth: from a software company to a drug discovery biotech

    By Montserrat CasesNews, Science

    This public-private partnership will establish a framework for collaboration that promotes the creation of synergies between both institutions. Chemotargets has entered into a strategic alliance with the IMIM Hospital del…

    Read More
    2020-05-25
    Love0
    News collection

    The FDA licenses Chemotargets CLARITY platform

    By Montserrat CasesNews, Products

    The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) has licensed the Chemotargets CLARITY® platform for predicting unknown secondary targets for new molecules of pharmaceutical interest….

    Read More
    2020-05-06
    Love0
    News collection

    Chemotargets opens an investment round to enter a new phase of growth

    By Montserrat CasesNews

    GENESIS Biomed and CREA Inversión will advise in the funding, which will allow the company to expand its activity in the discovery of new drugs. Barcelona, 14 April 2020 –…

    Read More
    2020-04-16
    Love0
    News collection

    CANCELED – Chemotargets SL will present CLARITY® V4.0 at SOT2020, 15-19th March 2020, Anaheim (us)

    By Montserrat CasesDissemination, News, Products

    PS: SOT conference has been canceled due to the global situation regarding COVID-19 Chemotargets will participate at the Society of Toxicology Annual meeting (SOT2020) in Anaheim, California (US), March 15-19,…

    Read More
    2020-03-02
    Love0
    • « Previous
    • 1
    • 2
    • 3
    • Next »

    Categories

    • Dissemination
    • News
    • Press Release
    • Products
    • Science

    About

    Products

    SafetySuite

    SafetyVista

    CIPsee

    CLARITY

    Services

    Drug Safety

    Repurposing

    Discovery

    Pipeline

    Science

    News

    Contact

    © 2026 Chemotargets. Copyright and Legal Notice - Cookie Policy

      Close Menu
      • About
      • Products
        • SafetySuite
        • SafetyVista
        • CIPsee
        • CLARITY
      • Services
        • Drug Safety
        • Repurposing
        • Discovery
      • Pipeline
      • Science
      • News
      • Careers
      • Contact